Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

517 ARTÍCULOS , VIENDO DEL 481 AL 495

Cognitive-motor dual-task interference in Alzheimer's disease, Parkinson's disease, and prodromal neurodegeneration: A scoping review

Longhurst JK, Rider JV, Cummings JL, John SE, Poston B, Landers MR.

Gait Posture. 2023 Sep;105:58-74. doi: 10.1016/j.gaitpost.2023.07.277. Epub 2023 Jul 17.

Defective lysosomal acidification: a new prognostic marker and therapeutic target for neurodegenerative diseases

Lo CH, Zeng J.

Transl Neurodegener. 2023 Jun 8;12(1):29. doi: 10.1186/s40035-023-00362-0.

[Treatment-Quo vadis neurodegeneration?]

Vöglein J, Levin J, Höglinger G.

Nervenarzt. 2023 Oct;94(10):904-912. doi: 10.1007/s00115-023-01544-x. Epub 2023 Oct 6.

Ketogenic therapies in Parkinson's disease, Alzheimer's disease, and mild cognitive impairment: An integrative review

Price S, Ruppar TM.

Appl Nurs Res. 2023 Dec;74:151745. doi: 10.1016/j.apnr.2023.151745. Epub 2023 Oct 28.

Expert elicitation of risk factors for progression to dementia in individuals with mild cognitive impairment

Wang M, Sajobi TT, Hogan DB, Ganesh A, Seitz DP, Chekouo T, Forkert ND, Borrie MJ, Camicioli R, Hsiung GR, Masellis M, Moorhouse P, Tartaglia MC, Ismail Z, Smith EE.

Alzheimers Dement. 2023 Oct;19(10):4542-4548. doi: 10.1002/alz.12987. Epub 2023 Mar 15.

Lipids as Emerging Biomarkers in Neurodegenerative Diseases

Wei J, Wong LC, Boland S.

Int J Mol Sci. 2023 Dec 21;25(1):131. doi: 10.3390/ijms25010131.

Molecularly imprinted polymers for the recognition of biomarkers of certain neurodegenerative diseases

Pilvenyte G, Ratautaite V, Boguzaite R, Samukaite-Bubniene U, Plausinaitis D, Ramanaviciene A, Bechelany M, Ramanavicius A.

J Pharm Biomed Anal. 2023 May 10;228:115343. doi: 10.1016/j.jpba.2023.115343. Epub 2023 Mar 14.

Updated Percentiles for the University of Pennsylvania Smell Identification Test in Adults 50 Years of Age and Older

Brumm MC, Pierz KA, Lafontant DE, Caspell-Garcia C, Coffey CS, Siderowf A, Marek K.

Neurology. 2023 Apr 18;100(16):e1691-e1701. doi: 10.1212/WNL.0000000000207077. Epub 2023 Feb 27.

Role of Exosomes in the Pathogenesis and Theranostic of Alzheimer's Disease and Parkinson's Disease

He A, Wang M, Li X, Chen H, Lim K, Lu L, Zhang C.

Int J Mol Sci. 2023 Jul 4;24(13):11054. doi: 10.3390/ijms241311054.

Fluid and Biopsy Based Biomarkers in Parkinson's Disease

Coughlin DG, Irwin DJ.

Neurotherapeutics. 2023 Jul;20(4):932-954. doi: 10.1007/s13311-023-01379-z. Epub 2023 May 3.

Sex and gender differences in Alzheimer's disease, Parkinson's disease, and Amyotrophic Lateral Sclerosis: A narrative review

Nicoletti A, Baschi R, Cicero CE, Iacono S, Re VL, Luca A, Schirò G, Monastero R; Gender Neurology Study Group of the Italian Society of Neurology.

Mech Ageing Dev. 2023 Jun;212:111821. doi: 10.1016/j.mad.2023.111821. Epub 2023 Apr 29.

Links between COVID-19 and Parkinson's disease/Alzheimer's disease: reciprocal impacts, medical care strategies and underlying mechanisms

Huang P, Zhang LY, Tan YY, Chen SD.

Transl Neurodegener. 2023 Jan 30;12(1):5. doi: 10.1186/s40035-023-00337-1.

Deep Brain Stimulation beyond the Clinic: Navigating the Future of Parkinson's and Alzheimer's Disease Therapy

Senevirathne DKL, Mahboob A, Zhai K, Paul P, Kammen A, Lee DJ, Yousef MS, Chaari A.

Cells. 2023 May 25;12(11):1478. doi: 10.3390/cells12111478.

Gait and/or balance disturbances associated with Alzheimer's dementia among older adults with amnestic mild cognitive impairment: A longitudinal observational study

Ahn S, Chung JW, Crouter SE, Lee JA, Lee CE, Anderson JG.

J Adv Nurs. 2023 Dec;79(12):4815-4827. doi: 10.1111/jan.15768. Epub 2023 Jun 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias